InvestorsObserver
×
News Home

Should You Buy Kaleido Biosciences Inc (KLDO) in Biotechnology Industry?

Tuesday, September 29, 2020 03:12 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Kaleido Biosciences Inc (KLDO) in Biotechnology Industry?

Kaleido Biosciences Inc (KLDO) is around the middle of the Biotechnology industry according to InvestorsObserver. KLDO received an overall rating of 39, which means that it scores higher than 39 percent of all stocks. Kaleido Biosciences Inc also achieved a score of 33 in the Biotechnology industry, putting it above 33 percent of Biotechnology stocks. Biotechnology is ranked 28 out of the 148 industries.

Overall Score - 39
KLDO has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on KLDO!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 39 would rank higher than 39 percent of all stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Kaleido Biosciences Inc Stock Today?

Kaleido Biosciences Inc (KLDO) stock is higher by 11.97% while the S&P 500 is down -0.55% as of 3:09 PM on Tuesday, Sep 29. KLDO is higher by $1.08 from the previous closing price of $9.02 on volume of 346,088 shares. Over the past year the S&P 500 has gained 11.98% while KLDO is higher by 34.13%. KLDO lost -$2.62 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Kaleido Biosciences Inc (KLDO) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App